title: [Efficacy of early reperfusion therapy at the acute stage of myocardial infarction in elderly patients: the USIK database].
abstract: The role of early reperfusion therapy at the acute stage of myocardial infarctus in elderly patients is debated. The aim of this study was to analyze the prognostic role of reperfusion with i.v. thrombolysis or primary PTCA in the nationwide USIK database, which prospectively included all pts admitted to a CCU for an AMI < 48 hours in France in November 1998. For the purpose of the present study, only patients admitted within 24 hours of AMI and with one-year follow-up available were included. Of the 1838 patients included, 785 were > 70 years-old, of whom 225 (29%) had early reperfusion therapy with thrombolysis (N = 173) or primary PTCA (N = 52). Patients treated with early reperfusion had a baseline profile that differed substantially from that of patients treated conventionally: women (31% vs 50%, p < 0.001), admission within six hours of symptom onset (84% vs 55%, p < 0.001), history of systemic hypertension (48% vs 60%, p < 0.002), stroke (5% vs 11%, p < 0.01), peripheral arterial disease (8% vs 18%, p < 0.001); congestive heart failure (5% vs 20%, p < 0.001) or previous MI (12% vs 25%, p < 0.001), more anterior location of current MI (40% vs 28%, p < 0.002). Overall one-year Kaplan-Meier survival was 78% for patients with versus 64% for those without reperfusion therapy (p < 0.01). In patients with Q wave myocardial infarction, Cox multivariate analysis showed that reperfusion therapy was an independent predictor of survival (RR 0.66; 95% Confidence Interval: 0.45-0.96), along with age, anterior location and history of congestive heart failure. Therefore, data from this large "real life" registry indicate that reperfusion therapy with either thrombolysis or primary PTCA is associated with improved one-year survival in patients over 70 years of age.
authors.affiliation: Service de cardiologie, hôpital européen Georges Pompidou, 20, rue Leblanc, 75015 Paris, France.
authors.forename: T
authors.initials: T
authors.lastname: Demicheli
authors.forename: J P
authors.initials: JP
authors.lastname: Cambou
authors.forename: L
authors.initials: L
authors.lastname: Vaur
authors.forename: N
authors.initials: N
authors.lastname: Genes
authors.forename: S
authors.initials: S
authors.lastname: Etienne
authors.forename: M
authors.initials: M
authors.lastname: Angioi
authors.forename: N
authors.initials: N
authors.lastname: Danchin
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D015906:Angioplasty, Balloon, Coronary; D003627:Data Interpretation, Statistical; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D015999:Multivariate Analysis; D009203:Myocardial Infarction / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D011379:Prognosis; D012042:Registries; D012307:Risk Factors; D012737:Sex Factors; D011795:Surveys and Questionnaires; D016019:Survival Analysis; D015912:Thrombolytic Therapy; D013997:Time Factors